CHICAGO, IL, November 10, 2026 /24-7PressRelease/ -- reptides, an independent peptide wiki, now grades 310 peptides and compounds from S to F on the strength of their published research. Each grade links to its sources, 4,819 in all, including 3,018 peer-reviewed papers checked against PubMed.

Each compound page says what the compound is, what the studies found and what they didn't. The semaglutide page cites the STEP 1 trial: 14.9% average weight loss over 68 weeks, against 2.4% on placebo. The BPC-157 page counts more than 200 rodent studies and no randomized trial in people.

Also on the site:

- 129 side-by-side comparisons
- 26 claim checks, like whether BPC-157 helps tendons heal
- 13 goal pages, such as recovery, skin and sleep
- A free 52-chapter guide with 1,761 sources
- Ask Reptides, which answers questions from the site's own grades and sources
- A lab report checker, a graded supplier board and 900+ anonymous community reports
- Briefs on the peptide market, including a compound-by-compound guide to US legal status
- An iOS app rated 4.7 stars

"Most of what you find about peptides online is somebody selling something," said Oskar, founder and editor of reptides. "If you're new, the first thing you need to know is what's been tested in people, what's only been tested in rats and what hasn't been tested at all. That's what the letter tells you. And every source is right there, so you can check our work."

The compound pages, tier list, source index, goal pages and guide are free to read with no account. A one-time $100 license unlocks the rest, including unlimited Ask.

reptides is a research reference, not medical advice.

reptides (reptides.co) is an independent peptide wiki. It has no investors or sponsors and carries no peptide-vendor affiliate links. Its only revenue is paid reader access.

# # #